Condition: Heparin-induced Thrombocytopenia · Sponsor: Aspen Global Incorporated
An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Treatment of Subjects with Acute HIT (HITSOVA study)
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Shands University of Florida | Gainesville, Florida, United States | — |
| University of Minnesota Medical Center | Minneapolis, Minnesota, United States | — |
| Duke University Medical Center | Durham, North Carolina, United States | — |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | — |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | — |
| Clinical Center of the Republic of Srpska, Medical Intesnive Care Unit | Banja Luka, Republika Srpska, Bosnia and Herzegovina | — |
| University Clinical Centre of the Republic of Srpska, Clinic for cardiology | Banja Luka, Bosnia and Herzegovina | — |
| University Clinical Centre of the Republic of Srpska, Lung Clinic | Banja Luka, Bosnia and Herzegovina | — |
| Clinical Center University of Sarajevo, Clinic for Heart, Blood Vessels and Rheumatic Diseases | Sarajevo, Bosnia and Herzegovina | — |
| Clinical Center University of Sarajevo, Clinic for Lung Diseases | Sarajevo, Bosnia and Herzegovina | — |
| Jewish General Hospital | Montreal, Canada | — |
| CHU St Etienne; Avenue Albert Raimond | Saint-Priest-en-Jarez, Auvergne-Rhône-Alpes, France | — |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03809481